BASEPATH CO – Trademark Portfolio

Entity Type: 03

BASEPATH CO holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include BASEPATH. The owner is based in Sausalito, CA.

91 Filbert Ave

Sausalito, CA 94965

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

BASEPATH
BASEPATH
Registered 2024
Trademark
Serial #98742479
Registered 2024
NIL OS
NIL OS
Abandoned 2024

Trademark Classifications

BASEPATH CO's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (3 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does BASEPATH CO have?

BASEPATH CO has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned.

What trademark classes does BASEPATH CO file in?

BASEPATH CO files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.

What are BASEPATH CO's most well-known trademarks?

BASEPATH CO's registered trademark portfolio includes well-known marks such as BASEPATH. These are among 2 currently registered trademarks in the portfolio.

What is BASEPATH CO's trademark registration success rate?

BASEPATH CO has a 67% trademark registration rate, with 2 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.